CD8A and kidney cancer: Using flow-cytometry analysis, we identified CD4+CD8+ double positive (DP) T cells in peripheral blood mononuclear cells (PBMCs) from HD and from patients (Table 1) with bladder, prostate or kidney cancers (Figures 1A,B).